Cargando…
Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142891/ https://www.ncbi.nlm.nih.gov/pubmed/34041039 http://dx.doi.org/10.3389/fonc.2021.694036 |
Ejemplares similares
-
CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
por: Lu, Tongyi, et al.
Publicado: (2020) -
Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
por: Zhu, Wenhui, et al.
Publicado: (2020) -
CRISPR/Cas9 Editing of the Polyomavirus Tumor Antigens Inhibits Merkel Cell Carcinoma Growth In Vitro
por: Temblador, Arturo, et al.
Publicado: (2019) -
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
por: Zhang, Wen-Wei, et al.
Publicado: (2015) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
por: Kang, Yu, et al.
Publicado: (2019)